These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 25727016)
1. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1. Zhang Y; Duan G; Feng S Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1. Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034 [TBL] [Abstract][Full Text] [Related]
3. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin. Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736 [TBL] [Abstract][Full Text] [Related]
4. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1. Yan H; Zhang B; Fang C; Chen L Anticancer Drugs; 2018 Jun; 29(5):440-448. PubMed ID: 29494357 [TBL] [Abstract][Full Text] [Related]
5. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1. Long X; Lin XJ J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma. Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis. Zhou B; Li L; Li Y; Sun H; Zeng C Biomed Pharmacother; 2018 Oct; 106():850-857. PubMed ID: 30119255 [TBL] [Abstract][Full Text] [Related]
8. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22. Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291 [TBL] [Abstract][Full Text] [Related]
9. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene. Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349 [TBL] [Abstract][Full Text] [Related]
10. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin. Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665 [TBL] [Abstract][Full Text] [Related]
11. MiR-34c inhibits osteosarcoma metastasis and chemoresistance. Xu M; Jin H; Xu CX; Bi WZ; Wang Y Med Oncol; 2014 Jun; 31(6):972. PubMed ID: 24802328 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑487b‑3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3. Cheng M; Duan PG; Gao ZZ; Dai M Oncol Rep; 2020 Dec; 44(6):2691-2700. PubMed ID: 33125503 [TBL] [Abstract][Full Text] [Related]
13. Expression of MicroRNA-301a and its Functional Roles in Malignant Melanoma. Cui L; Li Y; Lv X; Li J; Wang X; Lei Z; Li X Cell Physiol Biochem; 2016; 40(1-2):230-244. PubMed ID: 27855389 [TBL] [Abstract][Full Text] [Related]
14. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy. Wang Z; Liu Z; Wu S Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557 [TBL] [Abstract][Full Text] [Related]
16. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells. Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p. Cheng FH; Zhao ZS; Liu WD Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of circITCH promotes osteosarcoma development and resistance to doxorubicin via the miR-524/RASSF6 axis. Zhou W; Liu Y; Wu X J Gene Med; 2021 Oct; 23(10):e3373. PubMed ID: 34151476 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-301a inhibits the progression of osteosarcoma by regulating DEC2. Wu H; Yu Z; Chen Q; Li D; Chen W J BUON; 2020; 25(2):1013-1021. PubMed ID: 32521900 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1. Fan L; Zhu C; Qiu R; Zan P; Zheng Z; Xu T; Li G Cell Physiol Biochem; 2017; 41(5):1935-1946. PubMed ID: 28391262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]